Patents by Inventor Stephen J. Morris

Stephen J. Morris has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11135398
    Abstract: A rigidizing device includes an elongate flexible tube, a braid layer positioned over the elongate flexible tube, an outer layer over the flexible tube and the braid layer, and an inlet between the elongate flexible tube and the outer layer and configured to attach to a source of vacuum or pressure. The braid layer has a plurality of strands braided together at a braid angle of 5-40 degrees relative to a longitudinal axis of the elongate flexible tube when the elongate flexible tube is straight. The rigidizing device is configured to have a rigid configuration when vacuum or pressure is applied through the inlet and a flexible configuration when vacuum or pressure is not applied through the inlet. The braid angle is configured to change as the rigidizing device bends when the rigidizing device is in the flexible configuration.
    Type: Grant
    Filed: January 19, 2021
    Date of Patent: October 5, 2021
    Assignee: Neptune Medical Inc.
    Inventors: Alexander Q. Tilson, Stephen J. Morris, Garrett J. Gomes, Adam S. Wigginton, Mark C. Scheeff, Charles S. Love
  • Publication number: 20210306812
    Abstract: Systems and methods for proactively identifying and surfacing relevant content on an electronic device with a touch-sensitive display are disclosed herein. In one aspect, a method includes presenting content in a first application. At least a portion of the content is presented without requiring input from a user. The method further includes receiving a request to open a second application. In response to receiving the request, the second application is presented with an input-receiving field. Before receiving any user input at the input-receiving field, a selectable user interface object is displayed with an indication that the portion of the content was viewed in the first application, allowing the user to paste at least the portion of the content into the input-receiving field. In response to detecting a selection of the selectable user interface object, the portion of the content is pasted into the input-receiving field.
    Type: Application
    Filed: June 11, 2021
    Publication date: September 30, 2021
    Inventors: Daniel C. GROSS, Patrick L. COFFMAN, Richard R. DELLINGER, Christopher P. FOSS, Jason J. GAUCI, Aria D. HAGHIGHI, Cyrus D. IRANI, Bronwyn A. JONES, Gaurav KAPOOR, Stephen O. LEMAY, Colin C. MORRIS, Michael R. SIRACUSA, Lawrence Y. YANG, Brent D. RAMERTH, Jerome R. BELLEGARDA, Jannes G.A. DOLFING, Giulia P. PAGALLO, Xin WANG, Jun HATORI, Alexandre R. MOHA, Kevin D. CLARK, Karl Christian KOHLSCHUETTER, Jesper A. ANDERSEN, Hafid ARRAS, Alexandre CARLHIAN, Thomas DENIAU, Mathieu J. MARTEL, Sofiane TOUDJI
  • Publication number: 20210138187
    Abstract: A rigidizing device includes an elongate flexible tube, a braid layer positioned over the elongate flexible tube, an outer layer over the flexible tube and the braid layer, and an inlet between the elongate flexible tube and the outer layer and configured to attach to a source of vacuum or pressure. The braid layer has a plurality of strands braided together at a braid angle of 5-40 degrees relative to a longitudinal axis of the elongate flexible tube when the elongate flexible tube is straight. The rigidizing device is configured to have a rigid configuration when vacuum or pressure is applied through the inlet and a flexible configuration when vacuum or pressure is not applied through the inlet. The braid angle is configured to change as the rigidizing device bends when the rigidizing device is in the flexible configuration.
    Type: Application
    Filed: January 19, 2021
    Publication date: May 13, 2021
    Inventors: Alexander Q. TILSON, Stephen J. MORRIS, Garrett J. GOMES, Adam S. WIGGINTON, Mark C. SCHEEFF, Charles S. LOVE
  • Publication number: 20210137366
    Abstract: A device for distending a body lumen for enhanced visualization with a capsule endoscope includes a plurality of struts configured to extend from the capsule endoscope, a retention mechanism configured to attach the plurality of struts to the capsule endoscope, and a trigger configured to release the retention mechanism.
    Type: Application
    Filed: May 31, 2019
    Publication date: May 13, 2021
    Applicant: NEPTUNE MEDICAL INC.
    Inventors: Alexander Q. TILSON, Garrett J. GOMES, Stephen J. MORRIS, Eugene F. DUVAL, Adam S. WIGGINTON
  • Publication number: 20200385369
    Abstract: The present invention relates to a novel family of covalent kinases inhibitors. Compounds of this class have been found to have inhibitory activity against members of the Tec kinase family, particularly ITK, BTK, BMX, Tec and/or RLK. The present invention is directed to a compound of Formula I or pharmaceutically acceptable salt, solvate, solvate of salt, stereoisomer, tautomer, isotope, prodrug, complex or biologically active metabolite thereof, and its use in therapy.
    Type: Application
    Filed: January 8, 2020
    Publication date: December 10, 2020
    Inventors: Alain Laurent, Yannick Rose, Stephen J. Morris
  • Patent number: 10752615
    Abstract: The present invention relates to a novel family of covalent kinases inhibitors, compounds of this class have been found to have inhibitory activity against members of the TEC kinase family, particularly ITK and/or TXK, BTK, TEC and/or combinations thereof. The present invention is directed to a compound of Formula I or pharmaceutically acceptable salt, solvate, solvates of salt, stereoisomer, tautomer, isotope, prodrug, complex or biologically active metabolite thereof, for use in therapy.
    Type: Grant
    Filed: August 16, 2017
    Date of Patent: August 25, 2020
    Assignee: GB005, Inc.
    Inventors: Alain Laurent, Stephen J. Morris
  • Publication number: 20200247808
    Abstract: Compounds having the Formula (I), and enantiomers, diastereomers, pharmaceutically acceptable salts, solvates and solvates of salts thereof, (Formula I)) are useful as kinase inhibitors or modulators, including BTK modulation or inhibition, wherein X1, X2, m, m?, E and R1 are as defined herein.
    Type: Application
    Filed: September 9, 2016
    Publication date: August 6, 2020
    Inventors: Alain Laurent, Yannick Rose, Stephen J. Morris
  • Publication number: 20200215036
    Abstract: The present invention relates to a novel family of covalent kinases inhibitors. Compounds of this class have been found to have inhibitory activity against members of the TEC kinase family, particularly RLK (TXK). The present invention is directed to a compound of Formula (I) or pharmaceutically acceptable salt, solvate, solvates of salt, stereoisomer, tautomer, isotope, prodrug, complex or biologically active metabolite thereof, for use in therapy.
    Type: Application
    Filed: August 21, 2018
    Publication date: July 9, 2020
    Inventors: Alain Laurent, Stephen J. Morris
  • Publication number: 20200178763
    Abstract: A rigidizing overtube includes an elongate flexible tube, one or more mounting elements attached to the flexible tube, and a plurality of engagers connected to the one or more mounting elements. The rigidizing overtube has a flexible configuration in which the plurality of engagers are configured to move relative to other engagers to accommodate bending of the flexible tube. The rigidizing overtube also has a rigid configuration in which the plurality of engagers are fixed relative to other engagers to prevent the flexible tube from bending.
    Type: Application
    Filed: July 19, 2018
    Publication date: June 11, 2020
    Applicant: NEPTUNE MEDICAL INC.
    Inventors: Alexander Q. TILSON, Garrett J. GOMES, Stephen J. MORRIS, Eugene F. DUVAL, Adam S. WIGGINTON, Mark C. SCHEEFF
  • Patent number: 10562893
    Abstract: The present invention relates to a novel family of covalent kinases inhibitors. Compounds of this class have been found to have inhibitory activity against members of the Tec kinase family, particularly ITK, BTK, BMX, Tec and/or RLK. The present invention is directed to a compound of Formula I or pharmaceutically acceptable salt, solvate, solvate of salt, stereoisomer, tautomer, isotope, prodrug, complex or biologically active metabolite thereof and its use in therapy.
    Type: Grant
    Filed: September 22, 2016
    Date of Patent: February 18, 2020
    Assignee: GB005, INC.
    Inventors: Alain Laurent, Yannick Rose, Stephen J. Morris
  • Publication number: 20190263790
    Abstract: The present invention relates to a novel family of covalent kinases inhibitors, compounds of this class have been found to have inhibitory activity against members of the TEC kinase family, particularly ITK and/or TXK, BTK, TEC and/or combinations thereof. The present invention is directed to a compound of Formula I or pharmaceutically acceptable salt, solvate, solvates of salt, stereoisomer, tautomer, isotope, prodrug, complex or biologically active metabolite thereof, for use in therapy.
    Type: Application
    Filed: August 16, 2017
    Publication date: August 29, 2019
    Inventors: Alain Laurent, Stephen J. Morris
  • Publication number: 20180319781
    Abstract: The present invention relates to a novel family of covalent kinases inhibitors. Compounds of this class have been found to have inhibitory activity against members of the Tec kinase family, particularly ITK, BTK, BMX, Tec and/or RLK. The present invention is directed to a compound of Formula I or pharmaceutically acceptable salt, solvate, solvate of salt, stereoisomer, tautomer, isotope, prodrug, complex or biologically active metabolite thereof and its use in therapy.
    Type: Application
    Filed: September 22, 2016
    Publication date: November 8, 2018
    Inventors: Alain Laurent, Yannick Rose, Stephen J. Morris
  • Publication number: 20180179210
    Abstract: The present invention relates to a novel family of kinases inhibitors. Compounds of this class have been found to have inhibitory activity against members of the TEC kinase family, particularly BTK. The present invention is directed to a compound of Formula I or pharmaceutically acceptable salt, solvate, solvate of salt, stereoisomer, tautomer, isotope, prodrug, complex or biologically active metabolite thereof, for use in therapy.
    Type: Application
    Filed: May 27, 2016
    Publication date: June 28, 2018
    Applicant: Pharmascience Inc.
    Inventors: Alain Laurent, Yannick Rose, Stephen J. Morris
  • Publication number: 20150133731
    Abstract: Biological navigation devices and methods are disclosed. The devices can be used as or to support colonoscopies or endoscopes. The devices can have one or more releasable, and/or everting, and/or pressurized tubes. The devices can be removably attached to elongated elements, such as colonoscopes or other endoscopes.
    Type: Application
    Filed: September 26, 2014
    Publication date: May 14, 2015
    Inventors: Alexander Quillin TILSON, Gene DUVAL, Mitchell C. BARHAM, David P. KNIGHT, Roland J. DOWNS, Christopher Michael ADAMS, Stephen J. MORRIS, Mark Christopher SCHEEFF
  • Patent number: 8635327
    Abstract: Link traversals leading from an advertisement on the Web to a product page are determined. The determined link traversals are used as a basis for charging for advertising, for example, by counting the number of link traversals from the advertising page to a product page, or by counting the number of sales resulting from such traversals. The effectiveness of advertising on the Web is evaluated by measuring the number of sales or transactions resulting from link traversals from the advertisement to the page.
    Type: Grant
    Filed: April 12, 2000
    Date of Patent: January 21, 2014
    Assignee: Soverain Software LLC
    Inventors: Thomas Mark Levergood, Lawrence C. Stewart, Stephen J. Morris, Andrew C. Payne, George W. Treese
  • Patent number: 8028427
    Abstract: A stage for aligning a workpiece relative to analyzing apparatus. The stage has a platform and means for maintaining a workpiece on the platform. The platform is operable to tilt relative to the analyzing apparatus and thereby rotate the workpiece relative to the analyzing apparatus.
    Type: Grant
    Filed: March 28, 2008
    Date of Patent: October 4, 2011
    Assignee: Nightingale-EOD Ltd.
    Inventor: Stephen J. Morris
  • Patent number: 7772260
    Abstract: This invention relates to compounds of Formula I and the use of compounds of Formula I as neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems.
    Type: Grant
    Filed: April 6, 2006
    Date of Patent: August 10, 2010
    Assignee: Aegera Therapeutics Inc.
    Inventors: James B. Jaquith, Gerald Villeneuve, Alain Boudreault, Stephen J. Morris, Jon Durkin, John W. Gillard, Kimberley E. Hewitt, H. Nicholas Marsh
  • Publication number: 20100198016
    Abstract: Biological navigation devices and methods are disclosed. The devices can be used as or to support colonoscopies or endoscopes. The devices can have one or more releasable, and/or everting, and/or pressurized tubes. The devices can be removably attached to elongated elements, such as colonoscopes or other endoscopes.
    Type: Application
    Filed: July 30, 2009
    Publication date: August 5, 2010
    Inventors: Alexander Quillin TILSON, Gene DUVAL, Mitchell C. BARHAM, David P. KNIGHT, Roland J. DOWNS, Christopher Michael ADAMS, Stephen J. MORRIS, Mark Christopher SCHEEFF
  • Patent number: 7741349
    Abstract: This invention relates to compounds of Formula I and the use of compounds of Formula I as neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems.
    Type: Grant
    Filed: April 5, 2006
    Date of Patent: June 22, 2010
    Assignee: Aegera Therapeutics Inc.
    Inventors: James B. Jaquith, Gerald Villeneuve, Alain Boudreault, Stephen J. Morris, Jon Durkin, John W. Gillard, Kimberley Hewitt, H. Nicholas Marsh
  • Patent number: 7714003
    Abstract: This invention relates to compounds of Formula I and the use of compounds of Formula I as neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems.
    Type: Grant
    Filed: May 7, 2007
    Date of Patent: May 11, 2010
    Assignee: Aegera Therapeutics Inc.
    Inventors: James B. Jaquith, Alain Boudreault, Stephen J. Morris, Jon Durkin, John W. Gillard, Kimberley E. Hewitt